Bridger Management’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-305,002
| Closed | -$25.9M | – | 44 |
|
|
2019
Q4 | $25.9M | Sell |
305,002
-1,102,294
| -78% | -$73.5M | 1.87% | 24 |
|
|
2019
Q3 | $70.4M | Sell |
1,407,296
-906,718
| -39% | -$36.2M | 5.81% | 3 |
|
|
2019
Q2 | $84.4M | Sell |
2,314,014
-527,747
| -19% | -$17.2M | 6.62% | 1 |
|
|
2019
Q1 | $79.4M | Sell |
2,841,761
-218,910
| -7% | -$5.16M | 6.29% | 2 |
|
|
2018
Q4 | $58.6M | Buy |
3,060,671
+720,981
| +31% | +$16.8M | 4.88% | 5 |
|
|
2018
Q3 | $70M | Sell |
2,339,690
-265,275
| -10% | -$9.99M | 4.05% | 8 |
|
|
2018
Q2 | $95.6M | Sell |
2,604,965
-52,521
| -2% | -$1.71M | 5.18% | 3 |
|
|
2018
Q1 | $87.5M | Sell |
2,657,486
-151,468
| -5% | -$4.73M | 5.31% | 4 |
|
|
2017
Q4 | $76.8M | Hold |
2,808,954
| – | – | 5.07% | 6 |
|
|
2017
Q3 | $104M | Buy |
2,808,954
+347,714
| +14% | +$12.8M | 6.23% | 1 |
|
|
2017
Q2 | $93.6M | Buy |
2,461,240
+642,752
| +35% | +$28.6M | 5.34% | 1 |
|
|
2017
Q1 | $88.9M | Buy |
1,818,488
+193,974
| +12% | +$8.85M | 5.07% | 3 |
|
|
2016
Q4 | $55.1M | Sell |
1,624,514
-473,486
| -23% | -$16.8M | 3.83% | 10 |
|
|
2016
Q3 | $79.2M | Sell |
2,098,000
-314,501
| -13% | -$11.9M | 5.34% | 3 |
|
|
2016
Q2 | $81.1M | Sell |
2,412,501
-688,797
| -22% | -$24.3M | 5.24% | 3 |
|
|
2016
Q1 | $98.5M | Buy |
3,101,298
+184,777
| +6% | +$6.03M | 6.81% | 1 |
|
|
2015
Q4 | $109M | Buy |
2,916,521
+450,316
| +18% | +$17M | 3.6% | 3 |
|
|
2015
Q3 | $93.6M | Sell |
2,466,205
-24,806
| -1% | -$871K | 6.39% | 2 |
|
|
2015
Q2 | $71.3M | Buy |
2,491,011
+537,878
| +28% | +$15M | 2.25% | 6 |
|
|
2015
Q1 | $54.7M | Sell |
1,953,133
-1,178,051
| -38% | -$33.1M | 3.66% | 12 |
|
|
2014
Q4 | $86.6M | Buy |
3,131,184
+25,088
| +0.8% | +$622K | 5.45% | 1 |
|
|
2014
Q3 | $69.3M | Buy |
3,106,096
+1,247,358
| +67% | +$31.7M | 4.72% | 1 |
|
|
2014
Q2 | $54M | Buy |
+1,858,738
| New | +$49.6M | 3.8% | 9 |
|
|
2014
Q1 | – | Sell |
-630,000
| Closed | -$24.3M | – | 47 |
|
|
2013
Q4 | $24.3M | Buy |
+630,000
| New | +$22.5M | 1.7% | 28 |
|
|
2013
Q3 | – | Sell |
-1,410,000
| Closed | -$43.4M | – | 45 |
|
|
2013
Q2 | $43.4M | Buy |
+1,410,000
| New | +$47.2M | 3.19% | 15 |
|
Other funds holding MDCO
Bridger Management's MDCO Position: Q1 2020 in Review
Bridger Management sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 305,002 shares — an estimated $25.9M sold.
Bridger Management first reported a position in MDCO in Q2 2013 and held it in 25 quarters. The position peaked at $109M in Q4 2015. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- Bridger Management reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- Bridger Management sold 305,002 Medicines Co shares in Q1 2020, an estimated $25.9M.
- Bridger Management first reported a position in Medicines Co in Q2 2013 and held it in 25 quarters.
- Bridger Management's Medicines Co position peaked at $109M in Q4 2015.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on Bridger Management's 13F filing for Q1 2020, filed 15 May 2020.